Effect of dual inhibition of apoptosis and autophagy in prostate cancer

Prostate

Volumn 72, Issue 12, 2012, Pages 1374-1381

  Saleem, Ahamed ^a,d   Dvorzhinski, Dmitri ^a   Santanam, Urmila ^a   Mathew, Robin ^a   Bray, Kevin ^a   Stein, Mark ^a,b   White, Eileen ^a,b,c   Dipaola, Robert S ^a,b  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d QASSIM UNIVERSITY   (Saudi Arabia)

Author keywords

ABT 263; ABT 737; autophagy; Bcl 2; BH3; metabolism; prostate cancer

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; BIOLOGICAL MARKER; HYDROXYCHLOROQUINE; PROTEIN P62; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; HUMAN; HUMAN CELL; MITOPHAGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; AUTOPHAGY; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYCHLOROQUINE; MALE; MICE; MICE, NUDE; NITROPHENOLS; PIPERAZINES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; SULFONAMIDES; TREATMENT OUTCOME; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84864284745     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22487     Document Type: Article

References (20)

1. Castilla C, Congregado B, Chinchon D, Torrubia FJ, Japon MA, Saez C,. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak. Endocrinology 2006; 147 (10): 4960-4967. (Pubitemid 44402203)
2. Yoshino T, Shiina H, Urakami S, Kikuno N, Yoneda T, Shigeno K, Igawa M,. Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. Clin Cancer Res 2006; 12 (20 Pt 1): 6116-6124. (Pubitemid 44703777)
3. Lin Y, Fukuchi J, Hiipakka RA, Kokontis JM, Xiang J,. Up-regulation of Bcl-2 is required for the progression of prostate cancer cells from an androgen-dependent to an androgen-independent growth stage. Cell Res 2007; 17 (6): 531-536. (Pubitemid 46980949)
4. Cragg MS, Harris C, Strasser A, Scott CL,. Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics. Nat Rev Cancer 2009; 9 (5): 321-326.
5. Chonghaile TN, Letai A,. Mimicking the BH3 domain to kill cancer cells. Oncogene 2008; 27 (Suppl. 1): S149-S157.
6. Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, Bruncko M, Deckwerth TL, Dinges J, Hajduk PJ, Joseph MK, Kitada S, Korsmeyer SJ, Kunzer AR, Letai A, Li C, Mitten MJ, Nettesheim DG, Ng S, Nimmer PM, O'Connor JM, Oleksijew A, Petros AM, Reed JC, Shen W, Tahir SK, Thompson CB, Tomaselli KJ, Wang B, Wendt MD, Zhang H, Fesik SW, Rosenberg SH,. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435 (7042): 677-681. (Pubitemid 40825512)
7. Bray K, Chen HY, Karp CM, May M, Ganesan S, Karantza-Wadsworth V, DiPaola RS, White E,. Bcl-2 modulation to activate apoptosis in prostate cancer. Mol Cancer Res 2009; 7 (9): 1487-1496.
8. Hikita H, Takehara T, Shimizu S, Kodama T, Shigekawa M, Iwase K, Hosui A, Miyagi T, Tatsumi T, Ishida H, Li W, Kanto T, Hiramatsu N, Hayashi N,. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib. Hepatology 2010; 52 (4): 1310-1321.
9. Kim KW, Moretti L, Mitchell LR, Jung DK, Lu B,. Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model. Clin Cancer Res 2009; 15 (19): 6096-6105.
10. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT, White E,. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 2011; 17 (4): 654-666.
11. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Vzunbas G, Kamphorst JJ, Chen G, Lemons JM, Karantza V, Coller HA, Dipaola RS, Gelinas C, Rabinowitz JD, White E,. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 2011; 25 (5): 460-470.
12. White E, DiPaola RS,. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res 2009; 15 (17): 5308-5316.
13. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, Dipaola RS, Karantza-Wadsworth V, White E,. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137 (6): 1062-1075.
14. DiPaola RS, Dvorzhinski D, Thalasila A, Garikapaty V, Doram D, May M, Bray K, Mathew R, Beaudoin B, Karp C, Stein M, Foran DJ, White E,. Therapeutic starvation and autophagy in prostate cancer: A new paradigm for targeting metabolism in cancer therapy. Prostate 2008; 68 (16): 1743-1752.
15. Huang S, Sinicrope FA,. Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells. Autophagy 2010; 6 (2): 256-269.
16. Gao P, Bauvy C, Souquere S, Tonelli G, Liu L, Zhu Y, Qiao Z, Bakula D, Proikas-Cezanne T, Pierron G, Codogno P, Chen Q, Mehrpour M,. The Bcl-2 homology domain 3 mimetic gossypol induces both Beclin 1-dependent and Beclin 1-independent cytoprotective autophagy in cancer cells. J Biol Chem 2010; 285 (33): 25570-25581.
17. Tanida I, Waguri S,. Measurement of autophagy in cells and tissues. Methods Mol Biol 2010; 648: 193-214.
18. Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M, Bray K, Eddy S, Goodin S, White E, Dipaola RS,. Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate 2010; 70 (13): 1388-1394.
19. Watanabe Y, Tanaka M,. p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate. J Cell Sci 2011; 124 (Pt 16): 2692-2701.
20. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A,. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 2009; 106 (8): 2770-2775.